Mind Medicine News

Mind Medicine Analyst Ratings

BenzingaApr 15 10:28 ET

Mind Medicine Analyst Ratings

BenzingaMar 14 07:17 ET

Mind Medicine Analyst Ratings

BenzingaMar 8 05:34 ET

Mind Medicine Analyst Ratings

BenzingaMar 7 11:34 ET

Mind Medicine Analyst Ratings

BenzingaMar 1 14:12 ET

Mind Medicine Analyst Ratings

BenzingaFeb 29 12:13 ET

RBC Lifts Price Target on Mind Medicine (MindMed) to $15 From $14, Notes Imminent Durability Data; Outperform, Speculative Risk Kept

MT NewswiresFeb 29 07:52 ET

Mind Medicine (MMED) Receives a Buy From Maxim Group

TipRanksDec 15, 2023 15:11 ET

Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)

TipRanksNov 4, 2023 11:00 ET

Mind Medicine Analyst Ratings

BenzingaOct 23, 2023 11:43 ET

Cantor Fitzgerald Reiterates Overweight on Mind Medicine, Maintains $7 Price Target

BenzingaAug 22, 2023 09:56 ET

Mind Medicine Analyst Ratings

BenzingaAug 22, 2023 09:55 ET

Mind Medicine (MMED) Gets a Buy Rating From H.C. Wainwright

TipRanksAug 4, 2023 11:50 ET

EF Hutton Reiterates Buy on Mind Medicine, Maintains $21 Price Target

BenzingaAug 4, 2023 08:13 ET

Mind Medicine Analyst Ratings

BenzingaAug 4, 2023 08:13 ET

RBC Raises Price Target on Mind Medicine (MindMed) to $7 From $5, Maintains Outperform, Speculative Risk

MT NewswiresAug 4, 2023 07:49 ET

RBC Capital Reiterates Outperform on Mind Medicine, Maintains $5 Price Target

BenzingaJul 10, 2023 08:33 ET

The Latest Analyst Ratings for Mind Medicine

BenzingaJun 28, 2023 16:00 ET

HC Wainwright & Co. Reiterates Buy on Mind Medicine, Maintains $75 Price Target

BenzingaJun 28, 2023 13:01 ET

RBC Capital Reiterates Outperform on Mind Medicine, Maintains $5 Price Target

BenzingaJun 21, 2023 09:15 ET